35 related articles for article (PubMed ID: 18080952)
1. Myelodysplastic Syndromes and Metabolism.
Balaian E; Wobus M; Bornhäuser M; Chavakis T; Sockel K
Int J Mol Sci; 2021 Oct; 22(20):. PubMed ID: 34681910
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin and the use of a transgenic model of erythropoietin-deficient mice.
Pichon A; Jeton F; El Hasnaoui-Saadani R; Hagström L; Launay T; Beaudry M; Marchant D; Quidu P; Macarlupu JL; Favret F; Richalet JP; Voituron N
Hypoxia (Auckl); 2016; 4():29-39. PubMed ID: 27800506
[TBL] [Abstract][Full Text] [Related]
3. Erythropoietin Does Not Enhance Skeletal Muscle Protein Synthesis Following Exercise in Young and Older Adults.
Lamon S; Zacharewicz E; Arentson-Lantz E; Gatta PA; Ghobrial L; Gerlinger-Romero F; Garnham A; Paddon-Jones D; Russell AP
Front Physiol; 2016; 7():292. PubMed ID: 27458387
[TBL] [Abstract][Full Text] [Related]
4. RhEPO improves time to exhaustion by non-hematopoietic factors in humans.
Annaheim S; Jacob M; Krafft A; Breymann C; Rehm M; Boutellier U
Eur J Appl Physiol; 2016 Mar; 116(3):623-33. PubMed ID: 26729211
[TBL] [Abstract][Full Text] [Related]
5. Satellite cell response to erythropoietin treatment and endurance training in healthy young men.
Hoedt A; Christensen B; Nellemann B; Mikkelsen UR; Hansen M; Schjerling P; Farup J
J Physiol; 2016 Feb; 594(3):727-43. PubMed ID: 26607845
[TBL] [Abstract][Full Text] [Related]
6. Erythropoietin, a novel versatile player regulating energy metabolism beyond the erythroid system.
Wang L; Di L; Noguchi CT
Int J Biol Sci; 2014; 10(8):921-39. PubMed ID: 25170305
[TBL] [Abstract][Full Text] [Related]
7. A non-erythropoietic peptide derivative of erythropoietin decreases susceptibility to diet-induced insulin resistance in mice.
Collino M; Benetti E; Rogazzo M; Chiazza F; Mastrocola R; Nigro D; Cutrin JC; Aragno M; Fantozzi R; Minetto MA; Thiemermann C
Br J Pharmacol; 2014 Dec; 171(24):5802-15. PubMed ID: 25164531
[TBL] [Abstract][Full Text] [Related]
8. The role and regulation of erythropoietin (EPO) and its receptor in skeletal muscle: how much do we really know?
Lamon S; Russell AP
Front Physiol; 2013; 4():176. PubMed ID: 23874302
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin contributes to slow oxidative muscle fiber specification via PGC-1α and AMPK activation.
Wang L; Jia Y; Rogers H; Suzuki N; Gassmann M; Wang Q; McPherron AC; Kopp JB; Yamamoto M; Noguchi CT
Int J Biochem Cell Biol; 2013 Jul; 45(7):1155-64. PubMed ID: 23523698
[TBL] [Abstract][Full Text] [Related]
10. Three weeks of erythropoietin treatment hampers skeletal muscle mitochondrial biogenesis in rats.
Martinez-Bello VE; Sanchis-Gomar F; Romagnoli M; Derbre F; Gomez-Cabrera MC; Viña J
J Physiol Biochem; 2012 Dec; 68(4):593-601. PubMed ID: 22627788
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin treatment enhances muscle mitochondrial capacity in humans.
Plenge U; Belhage B; Guadalupe-Grau A; Andersen PR; Lundby C; Dela F; Stride N; Pott FC; Helge JW; Boushel R
Front Physiol; 2012; 3():50. PubMed ID: 22419911
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of functional erythropoietin receptor status in skeletal muscle in vivo: acute and prolonged studies in healthy human subjects.
Christensen B; Lundby C; Jessen N; Nielsen TS; Vestergaard PF; Møller N; Pilegaard H; Pedersen SB; Kopchick JJ; Jørgensen JO
PLoS One; 2012; 7(2):e31857. PubMed ID: 22384088
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin is neuroprotective in a transgenic mouse model of multiple system atrophy.
Köllensperger M; Krismer F; Pallua A; Stefanova N; Poewe W; Wenning GK
Mov Disord; 2011 Feb; 26(3):507-515. PubMed ID: 21462262
[TBL] [Abstract][Full Text] [Related]
14. Skeletal muscle intrinsic functional properties are preserved in a model of erythropoietin deficient mice exposed to hypoxia.
Hagström L; Canon F; Agbulut O; Marchant D; Serrurier B; Richalet JP; Beaudry M; Bigard X; Launay T
Pflugers Arch; 2010 Apr; 459(5):713-23. PubMed ID: 20119684
[TBL] [Abstract][Full Text] [Related]
15. Blunting effect of hypoxia on the proliferation and differentiation of human primary and rat L6 myoblasts is not counteracted by Epo.
Launay T; Hagström L; Lottin-Divoux S; Marchant D; Quidu P; Favret F; Duvallet A; Darribère T; Richalet JP; Beaudry M
Cell Prolif; 2010 Feb; 43(1):1-8. PubMed ID: 20070732
[TBL] [Abstract][Full Text] [Related]
16. Association of the VEGFR2 gene His472Gln polymorphism with endurance-related phenotypes.
Ahmetov II; Hakimullina AM; Popov DV; Lyubaeva EV; Missina SS; Vinogradova OL; Williams AG; Rogozkin VA
Eur J Appl Physiol; 2009 Sep; 107(1):95-103. PubMed ID: 19521715
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin over-expression protects against diet-induced obesity in mice through increased fat oxidation in muscles.
Hojman P; Brolin C; Gissel H; Brandt C; Zerahn B; Pedersen BK; Gehl J
PLoS One; 2009 Jun; 4(6):e5894. PubMed ID: 19521513
[TBL] [Abstract][Full Text] [Related]
18. Erythropoietin induces a shift of muscle phenotype from fast glycolytic to slow oxidative.
Cayla JL; Maire P; Duvallet A; Wahrmann JP
Int J Sports Med; 2008 Jun; 29(6):460-5. PubMed ID: 18080952
[TBL] [Abstract][Full Text] [Related]
19. Nerve influence on myosin light chain phosphorylation in slow and fast skeletal muscles.
Bozzo C; Spolaore B; Toniolo L; Stevens L; Bastide B; Cieniewski-Bernard C; Fontana A; Mounier Y; Reggiani C
FEBS J; 2005 Nov; 272(22):5771-85. PubMed ID: 16279942
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
